# FDA Inspection 1191447 - Octapharma Plasma, Inc. - October 28, 2022

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/968d9f06-bf5e-4cdd-9935-7488a2e7e9c9
Source feed: FDA_Inspections

> FDA Inspection 1191447 for Octapharma Plasma, Inc. on October 28, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1191447
- Company Name: Octapharma Plasma, Inc.
- Inspection Date: 2022-10-28
- Classification: No Action Indicated (NAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1191447 - 2022-10-28](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/944604df-d5cd-46ec-86ab-c0267c170541)
- [FDA Inspection 1015098 - 2017-05-23](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/73b142d3-d207-43b2-9dec-8823b88e4ee5)
- [FDA Inspection 935859 - 2015-07-23](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/7e9be0d6-375a-4eb3-9e4d-fbd05d426457)
- [FDA Inspection 819769 - 2013-02-21](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/9300b637-4d29-48df-9058-58113cb4fb7d)
- [FDA Inspection 722288 - 2011-05-02](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/05b4a67c-52d5-4175-b2a7-6a75cb9bf5ce)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/ce79a43a-da67-4e55-ba2a-ad6129607f59

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d